Expression/NN
of/IN
c-fos/NN
,/,
c-jun/NN
and/CC
jun/NN
B/NN
in/IN
peripheral/JJ
blood/NN
lymphocytes/NNS
from/IN
young/JJ
and/CC
elderly/JJ
adults/NNS
./.

The/DT
expression/NN
of/IN
c-fos/NN
,/,
c-jun/NN
and/CC
jun/NN
B/NN
proto-oncogenes/NNS
was/VBD
studied/VBN
in/IN
phytohemagglutinin/NN
(/(
PHA/NN
)/)
activated/VBN
peripheral/JJ
blood/NN
lymphocytes/NNS
(/(
PBL/NN
)/)
from/IN
young/JJ
and/CC
aged/JJ
humans/NNS
./.
=====
Specific/JJ
mRNAs/NNS
for/IN
c-fos/NN
and/CC
c-jun/NN
were/VBD
detectable/JJ
within/IN
30/CD
min/NN
after/IN
cell/NN
activation/NN
and/CC
reached/VBD
maximal/JJ
levels/NNS
within/IN
2/CD
h/NN
./.
=====
Both/CC
c-fos/NN
and/CC
jun/NN
B/NN
mRNAs/NNS
decreased/VBD
to/TO
pre-activation/NN
levels/NNS
within/IN
6/CD
h/NN
,/,
while/IN
c-jun/NN
mRNA/NN
remained/VBD
elevated/JJ
./.
=====
In/IN
PHA-activated/JJ
PBL/NN
,/,
no/DT
age-related/JJ
differences/NNS
were/VBD
observed/VBN
in/IN
c-fos/NN
or/CC
jun/NN
B/NN
mRNA/NN
expression/NN
./.
=====
However/RB
,/,
c-jun/NN
mRNA/NN
levels/NNS
decreased/VBD
significantly/RB
(/(
1.73/CD
+/-/CC
0.08/CD
vs./CC
1.16/CD
+/-/CC
0.09/CD
arbitrary/JJ
units/NNS
,/,
P/NN
</JJR
0.01/CD
,/,
young/JJ
vs./CC
old/JJ
)/)
in/IN
PBL/NN
from/IN
elderly/JJ
individuals/NNS
activated/VBN
with/IN
PHA/NN
./.
=====
Because/IN
previous/JJ
work/NN
has/VBZ
demonstrated/VBN
that/IN
T/NN
cells/NNS
from/IN
elderly/JJ
individuals/NNS
may/MD
display/VB
normal/JJ
proliferative/JJ
responses/NNS
when/WRB
activated/VBN
via/IN
the/DT
anti-CD2/JJ
pathway/NN
,/,
c-jun/NN
and/CC
jun/NN
B/NN
mRNA/NN
expression/NN
was/VBD
also/RB
studied/VBN
in/IN
anti-CD2-activated/JJ
purified/VBN
T/NN
cells/NNS
./.
=====
No/DT
age-related/JJ
differences/NNS
were/VBD
found/VBN
in/IN
the/DT
expression/NN
of/IN
either/DT
of/IN
these/DT
two/CD
proto-oncogenes/NNS
by/IN
anti-CD2/NN
activated/JJ
T/NN
cells/NNS
./.
=====
These/DT
results/NNS
suggest/VBP
that/IN
the/DT
decreased/VBN
IL-2/NN
production/NN
and/CC
proliferative/JJ
response/NN
displayed/VBN
by/IN
PHA-activated/JJ
PBL/NN
from/IN
elderly/JJ
adults/NNS
may/MD
be/VB
related/JJ
to/TO
age-related/JJ
changes/NNS
in/IN
c-jun/NN
mRNA/NN
expression/NN
and/CC
in/IN
the/DT
ratio/NN
of/IN
c-fos/NN
to/TO
c-jun/NN
mRNA/NN
./.